KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
1-Year Return
51.8%
This Quarter Return
+4.95%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$141M
AUM Growth
-$13.1M
(-8.5%)
Cap. Flow
-$2.01M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
66.07%
Holding
39
New
3
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$909K |
| 2 |
Abeona Therapeutics
ABEO
|
$356K |
| 3 |
Royal Gold
RGLD
|
$258K |
| 4 |
Alamos Gold
AGI
|
$239K |
| 5 |
CGAU
Centerra Gold
CGAU
|
$170K |
Top Sells
| 1 |
Equinox Gold
EQX
|
$3.79M |
| 2 |
SKE
Skeena Resources
SKE
|
$318K |
Sector Composition
| 1 | Healthcare | 54.97% |
| 2 | Materials | 30.41% |
| 3 | Consumer Staples | 1.78% |
| 4 | Industrials | 1.73% |
| 5 | Financials | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aldeyra Therapeutics
ALDX
$334M
| $21M | 14.91% |
5,475,516
| – | – |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.6M | 8.98% |
895,269
+64,390
| +8% | +$909K |
|
3
Entera Bio
ENTX
$94.1M
| $11.2M | 7.95% |
5,881,879
| – | – |
|
4
SPDR Gold Trust
GLD
$112B
| $9.75M | 6.94% |
32,000
| – | – |
|
5
MeiraGTx Holdings
MGTX
$619M
| $8.15M | 5.79% |
1,250,000
| – | – |
|
6
Kinross Gold
KGC
$26.9B
| $6.88M | 4.89% |
440,000
| – | – |
|
7
Agnico Eagle Mines
AEM
$76.3B
| $6.6M | 4.69% |
55,500
| – | – |
|
8
Sandstorm Gold
SAND
$3.37B
| $6.58M | 4.68% |
700,000
| – | – |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.53B
| $5.31M | 3.78% |
600,000
| – | – |
|
10
Elicio Therapeutics
ELTX
$188M
| $4.87M | 3.46% |
630,915
| – | – |
|
|
SKE
11
Skeena Resources
SKE
$1.99B
| $4.7M | 3.34% |
295,400
-20,000
| -6% | -$318K |
|
|
SA
12
Seabridge Gold
SA
$1.81B
| $4.6M | 3.27% |
317,003
| – | – |
|
13
Altimmune
ALT
$334M
| $4.34M | 3.09% |
1,121,524
| – | – |
|
14
Franco-Nevada
FNV
$37.3B
| $4.1M | 2.91% |
25,000
| – | – |
|
|
MAG
15
DELISTED
MAG Silver
MAG
| $3.59M | 2.55% |
170,000
| – | – |
|
16
Nuvation Bio
NUVB
$1.33B
| $2.92M | 2.08% |
1,025,000
| – | – |
|
17
iShares Silver Trust
SLV
$20.1B
| $2.62M | 1.87% |
80,000
| – | – |
|
18
Applied Therapeutics
APLT
$68.2M
| $2.43M | 1.72% |
7,799,687
| – | – |
|
19
Ocular Therapeutix
OCUL
$2.37B
| $1.86M | 1.32% |
600,400
| – | – |
|
20
Philip Morris
PM
$251B
| $1.82M | 1.29% |
10,000
| – | – |
|
21
Visa
V
$666B
| $1.72M | 1.22% |
4,850
| – | – |
|
|
22
Royal Gold
RGLD
$12.2B
| $1.6M | 1.14% |
9,000
+1,450
| +19% | +$258K |
|
23
iShares US Aerospace & Defense ETF
ITA
$9.3B
| $1.44M | 1.03% |
7,650
| – | – |
|
24
Booz Allen Hamilton
BAH
$12.6B
| $1.35M | 0.96% |
13,000
| – | – |
|
|
25
Alamos Gold
AGI
$13.5B
| $1.33M | 0.94% |
50,000
+9,000
| +22% | +$239K |
|